31 January 2018

New EU plan to assess medicines’ added value will benefit consumers

Today, the EU Commission has proposed to reinforce Member States’ collaboration when they assess the added value of health technologies, such as medicines, medical devices or surgeries. This will lead to a better use of taxpayers’ money, in turn channelling money towards more innovative treatments and research. BEUC supports the idea of joining efforts to conduct Health Technology Assessment (HTA) in Europe and highlights some requirements to make the system work for consumers.
25 January 2018
24 January 2018

Our work areas

As consumers are faced with a growing amount of information from different sources, we advocate for high quality and non-promotional information about health products.

The ageing of the population, rising healthcare costs and the economic crisis are challenging the sustainability of healthcare systems and consumers’ access to treatments.

Health scandals such as the weight-loss drug Mediator and the faulty PIP breast implants keep undermining consumers’ confidence in the safety of available health products and their oversight by the competent authorities.

Our objectives

  • Ensure consumers have access to high quality healthcare in all EU Member States
  • Guarantee consumers benefit from safe and innovative treatments
  • Allow consumers to make informed choices regarding their health

Contact Card

The European Consumer Organisation
Europäischer Verbraucherverband
Bureau Européen des Unions de Consommateurs

Rue d'Arlon, 80 Bte 1 
B - 1040 Bruxelles

Tel: +32 2 743 15 93
E-mail: health@beuc.eu

Health Policy Officerpicture
Health Policy Officer
Francesca Cattarin
Communications Officerpicture
Communications Officer
Pauline Constant
Carmen Martin